diABZI STING agonist-1 (Tautomerism)

CAS号

2138498-18-5

分子式

C42H51N13O7

主要靶点

STING

仅限科研使用

Cat No : CM10450

Print datasheet

Synonyms

diABZI STING agonist-1|diABZI STING agonist|diABZI STING agonist (Compound 3)|Compound 3|STING|Tautomerism



产品信息

CAS号 2138498-18-5
分子式 C42H51N13O7
主要靶点 STING
主要通路 免疫与炎症
分子量 849.94
纯度 99.72%, 此纯度可做参考,具体纯度与批次有关系,可咨询客服
储存条件 store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | Shipping with blue ice.
别名 diABZI STING agonist-1|diABZI STING agonist|diABZI STING agonist (Compound 3)|Compound 3|STING|Tautomerism

靶点活性

STNG (human, PBMCs):130 nM (EC50)

体内活性

diABZI STING激动剂-1(异构体)(皮下注射;2.5 mg/kg)能够在体内诱导STING依赖性I型干扰素及促炎细胞因子的激活。diABZI STING激动剂-1(异构体)(静脉注射;3 mg/kg)表现出半衰期为1.4小时的全身暴露,并达到比STING在小鼠中的半最大有效浓度(EC50 200 ng/kg)高一半的系统浓度。diABZI STING激动剂-1(异构体)(静脉注射;1.5 mg/kg;43天)显著抑制肿瘤生长并显著提高生存率(P <0.001),其中8/10小鼠实现无肿瘤状态[1]。

体外活性

diABZI STING agonist-1 (Tautomerism) 是一种选择性干扰素基因(STING)受体激动剂,对人类及小鼠的EC50分别为130 nM和186 nM。在1 μM浓度下,diABZI STING agonist-1 (Tautomerism)对测试的350多种激酶表现出高度选择性[1]。

溶解度

DMSO:100 mg/mL (117.66 mM)

参考文献

1.Ramanjulu JM, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018 Nov 7.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2